FixRx

Speaker says House will review Senate PBM changes "through the lens of seeking relief for independent pharmacists" - Magnolia Tribune magnoliatribune.com/2026/03/12/spe…

💊 The $860 Million Medicare Oversight It’s hard to believe, but Medicare is currently overpaying by staggering amounts for single medications. A prime example is the cancer drug Abiraterone. The Cost Disparity The price difference between what Medicare pays and what an independent pharmacy can offer is eye-opening: Medicare Price: $2,800 per prescription Forest Park Pharmacy Price: $63 per prescription That is a difference of $2,737 per fill. Nationally, Medicare spends roughly $880 million on this drug annually. If sourced at the lower rate, the system could save $860 million every single year on this one medication alone. Why Is This Happening? The system often relies on an "Illusion of Savings." Here’s how the cycle typically works: High List Prices: Manufacturers set artificially high prices (e.g., $100 for a $25 drug). Rebate Games: Large rebates are paid to insurers to get the drug on "preferred lists." The Fallout: While the "net cost" might look lower to the insurer, patient co-pays and premiums are often based on the high list price, not the actual cost. Taking Control of Your Costs You don't have to be a victim of the "list price" trap. Forest Park Pharmacy uses transparent pricing that bypasses these inflated markups.

This is directly due to PBMs.

@FixRxorg Try calling and asking a mail order Pharmacist a question on your medication? Best service from independent pharmacy’s.

PBMs Should Not Own Pharmacies

Check the Facts — TDCI’s audit found OptumRx committed major PBM violations, with 18 findings and 5 observations including unfair reimbursements, improper appeals, and deficient audit processes—hurting pharmacies and patients. Full report: bit.ly/4aF2SNz #PBMReform

Arkansas Act 624: Reply Brief to 8th Circuit : “What’s in the public interest of Arkansans is to have their democratically enacted law enforced and to be protected from PBMs’ predatory practices.” @AGTimGriffin @SarahHuckabee @Commpharmacy @JeremiahMooreAR

Great closing line from this letter on the Tennessee #PBMReform bill: "The goal should be simple: a fair marketplace where local pharmacies can compete, and patients can access affordable medication." | @knoxnews ow.ly/AImN50YpEgj

Health insurance companies and PBMs are often presented as separate players in the healthcare chain. In reality, they're part of the same mega corporation. That means they aren't negotiating to get you the best price; they're negotiating within the same company.

Get a sneak peek at the 2026 Annual Convention! Watch this short video featuring a special message from PSOC President Stephen Andrews. bit.ly/3JPVcNB #PSOC #PharmacyCommunity #Convention2026

@NY_Pharmacists @TruthRX @Commpharmacy @psocrx @nyrxlaw

The PAPA bill will strengthen local pharmacies and expand patient access to essential care across New York. Right now, this bill is stalled in the Assembly—even as other legislation, like the patient‑notification bill, moved quickly. That contrast sends a troubling message: that highlighting barriers to care is being prioritized over actually fixing them. The Assembly leader  needs to hear directly from the people who rely on their pharmacies every day. Let them know that care close to home matters, and that the PAPA bill deserves a vote. @fairychloeee @CarlHeastieNY